肝胆胰外科杂志 ›› 2024, Vol. 36 ›› Issue (3): 161-167.doi: 10.11952/j.issn.1007-1954.2024.03.006

• 基础研究 • 上一篇    下一篇

沉默cFLIP在重症急性胰腺炎肺损伤中的作用机制研究

王宝枝,彭和平,张风华,黄海霞,陈育宾,杨学伟
  

  1. 广州医科大学附属第二医院番禺院区 普外科,广东 广州 511400
  • 接受日期:2023-09-26 出版日期:2024-03-15 发布日期:2024-03-27
  • 通讯作者: 杨学伟,主任医师,博士,Email:yangxw0908@163.com。
  • 作者简介:王宝枝(1980—),女,山西忻州人,副主任医师,硕士。
  • 基金资助:
    广东省医学科学技术研究基金项目(A2018087);西藏自治区自然科学基金组团式医学援藏项目(XZ2022ZR-ZY46(Z))。

Mechanism of silencing cFLIP in severe acute pancreatitis induced lung injury

WANG Baozhi, PENG Heping, ZHANG Fenghua, HUANG Haixia, CHEN Yubin, YANG Xuewei
  

  1. Department of General Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511400, China
  • Accepted:2023-09-26 Online:2024-03-15 Published:2024-03-27

摘要:

目的 探讨沉默细胞型Fas相关死亡区域蛋白样白介素-1β转换酶抑制蛋白(cFLIP)对重症急性胰腺炎(SAP)导致的肺损伤的影响及其可能的作用机制。方法 分别取12只SD大鼠,随机分为对照组、cFLIPL(或cFLIPS)siRNA1组、cFLIPL(或cFLIPS)siRNA2组和cFLIPL(或cFLIPS)siRNA3组,筛选抑制率最高的cFLIPL siRNA和cFLIPS siRNA。50只SD大鼠随机分成假手术组、模型对照组、cFLIP siRNA-NC组、cFLIPS siRNA组、cFLIPL siRNA组,每组各10只。通过胰胆管内逆行注射3%牛磺胆酸钠溶液建立SAP模型,建模成功后,cFLIPS siRNA、cFLIPL siRNA和cFLIP siRNA-NC组大鼠尾静脉注射对应siRNA溶液,其余组注射等量0.9% NaCl溶液。HE染色检测肺组织病理学变化;ELISA检测IL-6、IL-1β和TNF-α含量;全自动分析仪检测静脉血白细胞数、中性粒细胞数;流式细胞术检测中性粒细胞凋亡;Western blotting检测中性粒细胞RIP1和caspase-8蛋白表达。结果 cFLIPL siRNA2组以及cFLIPS siRNA1组干扰效率最明显,因此选择这2组进行后续实验(后续称为cFLIPL siRNA组和cFLIPL siRNA组)。与模型对照组大鼠相比,cFLIPL siRNA组和cFLIPS siRNA组大鼠肺泡结构损伤减轻,肺泡壁变薄,炎症细胞浸润减少;与模型对照组相比,cFLIPL siRNA组和cFLIPS siRNA组IL-6、IL-1β和TNF-α含量均明显降低,静脉血白细胞数、中性粒细胞数明显降低,中性粒细胞凋亡率明显升高,cFLIPL、cFLIPS和RIP1蛋白表达量明显降低,caspase-8蛋白表达量明显升高;以上差异均具有统计学意义(P<0.05)。结论 本研究结果表明,靶向沉默cFLIP可能通过上调caspase-8和抑制RIP1的表达,促进中性粒细胞凋亡,减少炎症介质IL-6、IL-1β和TNF-α释放,抑制肺组织中的中性粒细胞浸润,缓解SAP导致的肺损伤,在SAP中发挥保护作用。

关键词:

Abstract:

Objective To explore the role and possible mechanism of silencing cellular FLICE-like inhibitory protein (cFLIP) in severe acute pancreatitis (SAP) induced lung injury. Methods Twelve SD rats were randomly divided into the control group, cFLIPL (cFLIPS) siRNA1 group, cFLIPL (cFLIPS) siRNA2 group, and cFLIPL (cFLIPS) siRNA3 group. The cFLIPL siRNA and cFLIPS siRNA with the highest inhibition rate were screened. Fifty SD rats were randomly divided into the sham surgery group, model control group, cFLIP siRNA-NC group, cFLIPS siRNA group, and cFLIPL siRNA group. A SAP model was established by retrograde injection of 3%
sodium taurocholate solution into the pancreatic bile duct. After successful modeling, rats in the cFLIPS siRNA group, cFLIPL siRNA group, and cFLIP siRNA-NC group were injected with corresponding siRNA solution via the tail vein, while the remaining 2 groups were injected with an equal amount of 0.9% NaCl. HE staining was used to detect pathological changes in lung tissue; ELISA was used to detect the content of IL-6, IL-1β and TNF-α; The fully automatic analyzer was used to detect the number of white blood cells and neutrophils in venous blood; Neutrophil apoptosis was detected by flow cytometry; The expression of neutrophil RIP1 and
caspase-8 proteins were detected by Western blotting. Results The cFLIPL siRNA2 group and cFLIPS siRNA1 group showed the most significant interference efficiency, so these 2 groups were selected for subsequent experiments. Compared with the model control group rats, the cFLIPL siRNA group and cFLIPS siRNA group rats showed reduced alveolar structural damage, thinning of alveolar walls, and reduced infiltration of inflammatory cells. Compared with the model control group, the cFLIPL siRNA group and cFLIPS siRNA group showed that the contents of IL-6, IL-1β and TNF-α were significantly decreased, the numbers of white blood cells and neutrophils in venous blood were significantly decreased, the apoptosis rates of neutrophils were significantly increased, the expression levels of cFLIPL, cFLIPS, and RIP1 protein were significantly decreased, and the expression level of caspase-8 protein was significantly increased; the above differences were all statistically significant (P<0.05). Conclusion This experimental study suggests that, targeted silencing of cFLIP may promote neutrophil apoptosis by upregulating the expression of caspase-8 and inhibiting the expression of RIP1, and may reduce the release of inflammatory mediators IL-6, IL-1β and TNF-α, inhibit the neutrophil infiltration in lung tissue, and then alleviate the lung damage induced by SAP.


Key words:

中图分类号: 

  • R576
[1] 阮哲宇, 刘俊杰, 柯毅恒, 沈亦钰.
术前外周血NLR联合PLR在胰腺癌根治性切除术预后评估中的价值
[J]. 肝胆胰外科杂志, 2024, 36(2): 70-74.
[2] 钟平勇, 刘欣, 牟廷刚, 卿明, 谢飞.
胸腺肽α1对伴MVI的肝细胞癌患者解剖性肝切除术后免疫功能和预后的影响
[J]. 肝胆胰外科杂志, 2024, 36(1): 7-12.
[3] 申雪晗, 周江敏, 张志伟, 陈孝平. NLR对TACE联合仑伐替尼及免疫治疗的中晚期肝癌患者预后的预测价值[J]. 肝胆胰外科杂志, 2023, 35(1): 19-24.
[4] 肖繁, 刘袁君, 吴涯昆, 田银生, 戴毅. 重症急性胰腺炎合并血管并发症的研究现状与进展[J]. 肝胆胰外科杂志, 2022, 34(8): 508-512.
[5] 崔普泽, 胡彦建 , 贺旺 , 胡彦华.
Notch信号通路与肝癌细胞凋亡关系的研究进展
[J]. 肝胆胰外科杂志, 2021, 33(9): 573-.
[6] 孙永康, 唐才喜, 赵志坚. 感染性胰腺坏死精准化坏死组织清除术的现状与思考[J]. 肝胆胰外科杂志, 2021, 33(8): 449-.
[7] 潘龙飞, 王立明, 牛泽群, 冯辉, 孙江利, 裴红红, 任松, 秦斌, 单涛.
乌司他丁联合奥曲肽对重症急性胰腺炎患者炎症风暴和肺损伤的作用及机制
[J]. 肝胆胰外科杂志, 2021, 33(3): 147-151.
[8] 赵秀芬 , 李影 , 梁世耀 , 吴程为 , 卜斌茹 , 林陈婵. 重症急性胰腺炎患者区域动脉灌注导管 规范化护理方案的构建[J]. 肝胆胰外科杂志, 2021, 33(2): 109-113.
[9] 宁书蔚, 董志扬.
注射用西维来司他钠治疗急性胰腺炎引发的全身炎症反应综合征及急性肺损伤
[J]. 肝胆胰外科杂志, 2021, 33(10): 631-.
[10] 王强, 冯斌, 唐才喜, 赵志坚, 谢智钦. 微创技术联合胰周贯穿式灌洗引流治疗感染性胰腺坏死体会[J]. 肝胆胰外科杂志, 2020, 32(9): 557-562.
[11] 闫文科, 宿华威. 超声引导下经皮腹腔穿刺置管引流术在重症急性胰腺炎治疗中的应用总结[J]. 肝胆胰外科杂志, 2020, 32(4): 249-252.
[12] 周功挺 , 洪重 , 王兆洪 , 徐鲁白 , 王继生 , 周斌 , 张启瑜 , 廖毅.
中性粒细胞-淋巴细胞比值预测胆管结石相关的肝内胆管癌患者术后生存率
[J]. 肝胆胰外科杂志, 2020, 32(11): 672-685.
[13] 樊媛, 潘龙飞, 牛泽群, 王立明, 冯辉, 裴红红, 任松, 秦斌, 单涛.
乌司他丁联合CRRT对重症急性胰腺炎患者血管内皮功能和血小板活化因子的影响
[J]. 肝胆胰外科杂志, 2020, 32(10): 605-609.
[14] 柴振中, 冯文明, 黄三雄, 王耀. 胆道镜联合肾镜辅助经皮窦道清除重症急性胰腺炎胰周坏死组织[J]. 肝胆胰外科杂志, 2020, 32(1): 48-52.
[15] 蒋文竹 , 陈达伟 , 汤晓东 , 邓志成 . 连续性肾脏替代疗法联合腹腔灌洗在重症急性胰腺炎早期的临床应用[J]. 肝胆胰外科杂志, 2019, 31(9): 557-559.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © 2017 肝胆胰外科杂志 All Rights Reserved.
电话/传真:0577-86699363 E-mail: gdywkzz@vip.126.com
地址:浙江省温州市茶山高教园区温州医科大学图书馆A411室 邮编:325035
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:support@magtech.com.cn